Veracyte, Inc. has grown revenue 20% a year over three years and 35% a year over five. Revenue growth, 3-year annual rate: +20% (Diagnostics & Research median +9.1%). Revenue growth, 5-year rate: +35%, growth has slowed since the five-year average. Years of annual history on file: 15, FY2011 to FY2025, as filed.

VCYTVeracyte, Inc.

HealthcareUSD

$44.28

$27.3752 weeks$59.55

Is it growing?

Is VCYT growing?

Veracyte, Inc. has grown revenue 20% a year over three years and 35% a year over five.

+20%

Revenue growth, 3-year annual rate · Diagnostics & Research median +9.1% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +35%
Revenue growth, 5-year rate · +20% over three · growth has slowed since the five-year average
Years of annual history on file: 15
Years of annual history on file · FY2011 to FY2025, as filed

Details›